Novavax (NVAX) and DexCom (DXCM) are experiencing unusually high options trading volume today, with NVAX's options volume representing 51.4% of its average daily share volume and DXCM's at 49.3%. Notably, NVAX saw significant activity in its $9.50 strike call option expiring September 2025, while DXCM had high volume in its $77 strike put option expiring September 2025, suggesting potential directional positioning or hedging strategies for both equities over a longer horizon.
Novavax (NVAX) and DexCom (DXCM) are experiencing a significant surge in options market activity, indicating focused investor positioning. NVAX's options volume has reached 51.4% of its average daily share volume, with a notable concentration in the $9.50 strike call option expiring September 2025. This specific contract accounts for 15,702 contracts, representing approximately 1.6 million underlying shares, which suggests a substantial, long-term bullish speculation or a hedge against a significant short position. Conversely, DXCM's options volume is 49.3% of its average daily share volume, with a focus on the $77 strike put option, also expiring in September 2025. The 4,968 contracts traded in this put option point towards a significant bearish bet or a large-scale protective hedging strategy for a long equity position over the same extended timeframe. The divergent nature of these large, long-dated trades—bullish for NVAX and bearish/protective for DXCM—highlights specific, company-focused sentiment rather than a broader market trend.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
